Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	STAB2 LRP1B LDLR	9.65e-06	16	53	3	GO:0005041
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	STAB2 LRP1B LDLR	2.27e-05	21	53	3	GO:0030228
GeneOntologyMolecularFunction	calcium ion binding	STAB2 FBN1 OIT3 LPL LRP4 PLA2G5 PLCD1 GRIN1 LRP1B LDLR	2.35e-05	749	53	10	GO:0005509
GeneOntologyMolecularFunction	integrin binding	FBN1 TNC LAMB1 UTRN ADAM22	9.97e-05	175	53	5	GO:0005178
GeneOntologyMolecularFunction	zinc ion binding	BLVRA SETDB2 CAD TRIM42 MID2 MID1 ZMYM2 CUL9 NR3C2 UTRN	1.01e-04	891	53	10	GO:0008270
GeneOntologyMolecularFunction	lipoprotein particle binding	STAB2 LPL LDLR	1.09e-04	35	53	3	GO:0071813
GeneOntologyMolecularFunction	protein-lipid complex binding	STAB2 LPL LDLR	1.09e-04	35	53	3	GO:0071814
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	FBN1 LAMC1	4.49e-04	12	53	2	GO:0030023
GeneOntologyMolecularFunction	glycosphingolipid binding	LAMB1 LAMC1	5.29e-04	13	53	2	GO:0043208
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	FBN1 LAMC1	6.16e-04	14	53	2	GO:0097493
GeneOntologyMolecularFunction	transition metal ion binding	BLVRA SETDB2 CAD TRIM42 MID2 MID1 ZMYM2 CUL9 NR3C2 UTRN	1.01e-03	1189	53	10	GO:0046914
GeneOntologyMolecularFunction	low-density lipoprotein particle binding	STAB2 LDLR	1.03e-03	18	53	2	GO:0030169
GeneOntologyMolecularFunction	apolipoprotein binding	LPL LRP4	1.27e-03	20	53	2	GO:0034185
GeneOntologyMolecularFunction	cargo receptor activity	STAB2 LRP1B LDLR	1.50e-03	85	53	3	GO:0038024
GeneOntologyMolecularFunction	extracellular matrix structural constituent	FBN1 TNC LAMB1 LAMC1	1.55e-03	188	53	4	GO:0005201
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	TNC LAMB1 LAMC1	9.63e-06	17	52	3	GO:0098637
GeneOntologyCellularComponent	laminin-10 complex	LAMB1 LAMC1	1.82e-05	3	52	2	GO:0043259
GeneOntologyCellularComponent	laminin-1 complex	LAMB1 LAMC1	1.82e-05	3	52	2	GO:0005606
GeneOntologyCellularComponent	basement membrane	FBN1 TNC LAMB1 LAMC1	2.41e-04	122	52	4	GO:0005604
GeneOntologyCellularComponent	laminin complex	LAMB1 LAMC1	2.70e-04	10	52	2	GO:0043256
GeneOntologyCellularComponent	protein complex involved in cell adhesion	TNC LAMB1 LAMC1	4.28e-04	59	52	3	GO:0098636
GeneOntologyCellularComponent	filopodium membrane	SYNE2 UTRN	1.24e-03	21	52	2	GO:0031527
GeneOntologyCellularComponent	endoplasmic reticulum lumen	FBN1 TNC TOR1A LAMB1 LAMC1	1.38e-03	332	52	5	GO:0005788
GeneOntologyCellularComponent	cell surface	IFNG STAB2 LPL LRP4 PLA2G5 GRIN1 LRRTM1 LY6G5C LDLR	1.53e-03	1111	52	9	GO:0009986
MousePheno	increased locomotor activity	ARV1 TNC TOR1A GRIN1 UNC79 LDLR	9.02e-06	178	39	6	MP:0031391
Domain	EGF	STAB2 FBN1 OIT3 TNC LRP4 LAMB1 LAMC1 LRP1B LDLR ADAM22	8.18e-10	235	52	10	SM00181
Domain	EGF-like_dom	STAB2 FBN1 OIT3 TNC LRP4 LAMB1 LAMC1 LRP1B LDLR ADAM22	1.43e-09	249	52	10	IPR000742
Domain	EGF_1	STAB2 FBN1 OIT3 TNC LRP4 LAMB1 LAMC1 LRP1B LDLR ADAM22	1.80e-09	255	52	10	PS00022
Domain	EGF_2	STAB2 FBN1 OIT3 TNC LRP4 LAMB1 LAMC1 LRP1B LDLR ADAM22	2.61e-09	265	52	10	PS01186
Domain	Growth_fac_rcpt_	STAB2 FBN1 TNC LRP4 LAMB1 LAMC1 LRP1B LDLR	1.09e-08	156	52	8	IPR009030
Domain	EGF-like_CS	STAB2 FBN1 TNC LRP4 LAMB1 LAMC1 LRP1B LDLR ADAM22	3.86e-08	261	52	9	IPR013032
Domain	EGF_3	STAB2 FBN1 OIT3 TNC LRP4 LRP1B LDLR ADAM22	2.60e-07	235	52	8	PS50026
Domain	EGF_CA	STAB2 FBN1 OIT3 LRP4 LRP1B LDLR	1.09e-06	122	52	6	SM00179
Domain	EGF-like_Ca-bd_dom	STAB2 FBN1 OIT3 LRP4 LRP1B LDLR	1.20e-06	124	52	6	IPR001881
Domain	COS_domain	TRIM42 MID2 MID1	4.40e-06	12	52	3	IPR017903
Domain	COS	TRIM42 MID2 MID1	4.40e-06	12	52	3	PS51262
Domain	Ldl_recept_b	LRP4 LRP1B LDLR	7.25e-06	14	52	3	PF00058
Domain	LDLRB	LRP4 LRP1B LDLR	7.25e-06	14	52	3	PS51120
Domain	EGF_Ca-bd_CS	FBN1 OIT3 LRP4 LRP1B LDLR	7.30e-06	97	52	5	IPR018097
Domain	EGF_CA	FBN1 OIT3 LRP4 LRP1B LDLR	8.06e-06	99	52	5	PS01187
Domain	ASX_HYDROXYL	FBN1 OIT3 LRP4 LRP1B LDLR	8.47e-06	100	52	5	PS00010
Domain	LY	LRP4 LRP1B LDLR	9.05e-06	15	52	3	SM00135
Domain	LDLR_classB_rpt	LRP4 LRP1B LDLR	9.05e-06	15	52	3	IPR000033
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBN1 OIT3 LRP4 LRP1B LDLR	1.13e-05	106	52	5	IPR000152
Domain	EGF_extracell	STAB2 TNC LRP1B ADAM22	2.32e-05	60	52	4	IPR013111
Domain	EGF_2	STAB2 TNC LRP1B ADAM22	2.32e-05	60	52	4	PF07974
Domain	Butyrophylin	RFPL4A MID2 MID1 RFPL4AL1	4.28e-05	70	52	4	IPR003879
Domain	cEGF	FBN1 LRP4 LRP1B	5.06e-05	26	52	3	IPR026823
Domain	cEGF	FBN1 LRP4 LRP1B	5.06e-05	26	52	3	PF12662
Domain	RDM	RFPL4A RFPL4AL1	7.56e-05	5	52	2	PF11002
Domain	RDM_domain_RFPL	RFPL4A RFPL4AL1	7.56e-05	5	52	2	IPR022723
Domain	EGF_LAM_2	STAB2 LAMB1 LAMC1	7.84e-05	30	52	3	PS50027
Domain	EGF_LAM_1	STAB2 LAMB1 LAMC1	7.84e-05	30	52	3	PS01248
Domain	EGF_CA	FBN1 LRP4 LRP1B LDLR	9.58e-05	86	52	4	PF07645
Domain	SPRY	RFPL4A MID2 MID1 RFPL4AL1	1.00e-04	87	52	4	SM00449
Domain	EGF_Lam	STAB2 LAMB1 LAMC1	1.25e-04	35	52	3	SM00180
Domain	SPRY	RFPL4A MID2 MID1 RFPL4AL1	1.35e-04	94	52	4	PF00622
Domain	SPRY_dom	RFPL4A MID2 MID1 RFPL4AL1	1.35e-04	94	52	4	IPR003877
Domain	B30.2/SPRY	RFPL4A MID2 MID1 RFPL4AL1	1.41e-04	95	52	4	IPR001870
Domain	B302_SPRY	RFPL4A MID2 MID1 RFPL4AL1	1.41e-04	95	52	4	PS50188
Domain	Laminin_EGF	STAB2 LAMB1 LAMC1	1.60e-04	38	52	3	IPR002049
Domain	ZF_RING_2	RFPL4A TRIM42 MID2 MID1 CUL9 RFPL4AL1	1.72e-04	298	52	6	PS50089
Domain	-	LRP4 LRP1B LDLR	1.73e-04	39	52	3	2.120.10.30
Domain	LDLR_class-A_CS	LRP4 LRP1B LDLR	1.87e-04	40	52	3	IPR023415
Domain	PRY	RFPL4A MID1 RFPL4AL1	2.16e-04	42	52	3	PF13765
Domain	Ldl_recept_a	LRP4 LRP1B LDLR	2.66e-04	45	52	3	PF00057
Domain	Znf_RING	RFPL4A TRIM42 MID2 MID1 CUL9 RFPL4AL1	2.80e-04	326	52	6	IPR001841
Domain	-	LRP4 LRP1B LDLR	2.84e-04	46	52	3	4.10.400.10
Domain	6-blade_b-propeller_TolB-like	LRP4 LRP1B LDLR	2.84e-04	46	52	3	IPR011042
Domain	PRY	RFPL4A MID1 RFPL4AL1	3.22e-04	48	52	3	SM00589
Domain	LDLRA_1	LRP4 LRP1B LDLR	3.22e-04	48	52	3	PS01209
Domain	PRY	RFPL4A MID1 RFPL4AL1	3.22e-04	48	52	3	IPR006574
Domain	LDLRA_2	LRP4 LRP1B LDLR	3.43e-04	49	52	3	PS50068
Domain	LDrepeatLR_classA_rpt	LRP4 LRP1B LDLR	3.43e-04	49	52	3	IPR002172
Domain	LDLa	LRP4 LRP1B LDLR	3.43e-04	49	52	3	SM00192
Domain	EGF	STAB2 TNC LRP4 LRP1B	4.16e-04	126	52	4	PF00008
Domain	Bbox_C	MID2 MID1	7.80e-04	15	52	2	IPR003649
Domain	BBC	MID2 MID1	7.80e-04	15	52	2	SM00502
Domain	Laminin_N	LAMB1 LAMC1	8.90e-04	16	52	2	IPR008211
Domain	LAMININ_NTER	LAMB1 LAMC1	8.90e-04	16	52	2	PS51117
Domain	Laminin_N	LAMB1 LAMC1	8.90e-04	16	52	2	PF00055
Domain	LamNT	LAMB1 LAMC1	8.90e-04	16	52	2	SM00136
Domain	BBOX	TRIM42 MID2 MID1	9.37e-04	69	52	3	SM00336
Domain	zf-B_box	TRIM42 MID2 MID1	1.06e-03	72	52	3	PF00643
Domain	fn3	TRIM42 MID2 TNC MID1	1.07e-03	162	52	4	PF00041
Domain	Znf_RING_CS	TRIM42 MID2 MID1 CUL9	1.09e-03	163	52	4	IPR017907
Domain	ZF_RING_1	RFPL4A TRIM42 MID2 MID1 CUL9	1.27e-03	291	52	5	PS00518
Domain	ZF_BBOX	TRIM42 MID2 MID1	1.44e-03	80	52	3	PS50119
Domain	Znf_B-box	TRIM42 MID2 MID1	1.49e-03	81	52	3	IPR000315
Domain	RING	RFPL4A TRIM42 MID2 MID1 CUL9	1.56e-03	305	52	5	SM00184
Domain	FN3	TRIM42 MID2 TNC MID1	1.74e-03	185	52	4	SM00060
Domain	Actinin_actin-bd_CS	SYNE2 UTRN	1.85e-03	23	52	2	IPR001589
Domain	Spectrin	SYNE2 UTRN	1.85e-03	23	52	2	PF00435
Domain	ACTININ_2	SYNE2 UTRN	1.85e-03	23	52	2	PS00020
Domain	ACTININ_1	SYNE2 UTRN	1.85e-03	23	52	2	PS00019
Domain	FN3	TRIM42 MID2 TNC MID1	2.27e-03	199	52	4	PS50853
Domain	Galactose-bd-like	LAMB1 CUL9 LAMC1	2.28e-03	94	52	3	IPR008979
Domain	ARM-type_fold	URB1 INTS1 CUL9 HEATR1 UNC79	2.47e-03	339	52	5	IPR016024
Domain	FN3_dom	TRIM42 MID2 TNC MID1	2.71e-03	209	52	4	IPR003961
Pathway	PID_INTEGRIN3_PATHWAY	FBN1 TNC LAMB1 LAMC1	6.33e-06	43	40	4	M53
Pathway	PID_INTEGRIN1_PATHWAY	FBN1 TNC LAMB1 LAMC1	3.53e-05	66	40	4	M18
Pathway	REACTOME_ECM_PROTEOGLYCANS	TNC LRP4 LAMB1 LAMC1	6.15e-05	76	40	4	M27219
Pathway	REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION	LAMB1 LAMC1 UTRN	7.35e-05	29	40	3	M29808
Pathway	WP_INFLAMMATORY_RESPONSE_PATHWAY	IFNG LAMB1 LAMC1	8.15e-05	30	40	3	M39641
Pathway	WP_INFLAMMATORY_RESPONSE_PATHWAY	IFNG LAMB1 LAMC1	8.15e-05	30	40	3	MM15812
Pathway	BIOCARTA_LDL_PATHWAY	LPL LDLR	1.17e-04	6	40	2	M22051
Pathway	WP_OREXIN_RECEPTOR_PATHWAY	TNC LPL PLCD1 GRIN1 LDLR	2.40e-04	200	40	5	M48048
Pathway	WP_SPINAL_CORD_INJURY	IFNG PLA2G5 GRIN1 PLXNA2	2.41e-04	108	40	4	MM15954
Pathway	WP_SPINAL_CORD_INJURY	IFNG PLA2G5 GRIN1 PLXNA2	3.27e-04	117	40	4	M39341
Pathway	WP_LIPID_PARTICLES_COMPOSITION	LPL LDLR	3.48e-04	10	40	2	M39697
Pathway	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	FBN1 TNC LAMB1 LAMC1	4.08e-04	124	40	4	M27285
Pathway	PID_INTEGRIN4_PATHWAY	LAMB1 LAMC1	4.25e-04	11	40	2	M158
Pathway	BIOCARTA_PRION_PATHWAY	LAMB1 LAMC1	5.09e-04	12	40	2	M22020
Pathway	WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3	LPL LDLR	6.00e-04	13	40	2	M42551
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	TNC LAMB1 LAMC1	6.16e-04	59	40	3	M27218
Pathway	WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES	STAB2 ARV1 LPL LRP4 LRP1B LDLR	6.61e-04	381	40	6	M48063
Pathway	WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5	LPL LDLR	8.05e-04	15	40	2	M42552
Pathway	WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2	LPL LDLR	9.19e-04	16	40	2	M42564
Pathway	WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES	LPL LDLR	1.04e-03	17	40	2	M39747
Pathway	WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1	LPL LDLR	1.17e-03	18	40	2	M42559
Pathway	WP_STATIN_PATHWAY	LPL LDLR	1.30e-03	19	40	2	MM15868
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	FBN1 TNC LRP4 LAMB1 LAMC1	1.51e-03	300	40	5	M610
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	TNC LAMB1 LAMC1	1.72e-03	84	40	3	M7098
Pathway	WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4	LPL LDLR	1.75e-03	22	40	2	M42574
Pubmed	Detection of gelatinolytic activity in developing basement membranes of the mouse embryo head by combining sensitive in situ zymography with immunolabeling.	TNC LAMB1 LAMC1	2.79e-07	9	53	3	22688677
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	FBN1 TNC LAMB1 LAMC1	1.05e-06	50	53	4	23658023
Pubmed	cDNA cloning, expression and mapping of human laminin B2 gene to chromosome 1q31.	LAMB1 LAMC1	2.28e-06	2	53	2	3402995
Pubmed	A novel disulfide pattern in laminin-type epidermal growth factor-like (LE) modules of laminin β1 and γ1 chains.	LAMB1 LAMC1	2.28e-06	2	53	2	20731416
Pubmed	Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.	LPL LDLR	2.28e-06	2	53	2	9643345
Pubmed	The lowering of plasma lipids following a weight reduction program is related to increased expression of the LDL receptor and lipoprotein lipase.	LPL LDLR	2.28e-06	2	53	2	15795426
Pubmed	Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.	LPL LDLR	2.28e-06	2	53	2	24747115
Pubmed	Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.	LPL LDLR	2.28e-06	2	53	2	8692976
Pubmed	Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.	LPL LDLR	2.28e-06	2	53	2	30694319
Pubmed	Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice.	LPL LDLR	2.28e-06	2	53	2	10858435
Pubmed	Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.	PLA2G5 LDLR	2.28e-06	2	53	2	17204667
Pubmed	Computational modeling of laminin N-terminal domains using sparse distance constraints from disulfide bonds and chemical cross-linking.	LAMB1 LAMC1	2.28e-06	2	53	2	20939100
Pubmed	Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome.	MID2 MID1	2.28e-06	2	53	2	26788540
Pubmed	Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.	LPL LDLR	2.28e-06	2	53	2	26342331
Pubmed	Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosis.	SETDB2 LDLR	2.28e-06	2	53	2	34003795
Pubmed	Lipoprotein lipase-facilitated uptake of LDL is mediated by the LDL receptor.	LPL LDLR	2.28e-06	2	53	2	17090659
Pubmed	Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse.	IFNG LDLR	2.28e-06	2	53	2	12615659
Pubmed	TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts.	TNC LAMB1 LAMC1	2.68e-06	18	53	3	23041440
Pubmed	ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells.	FBN1 LAMB1 LAMC1	2.68e-06	18	53	3	39040056
Pubmed	MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm.	LRP4 LRP1B LDLR	4.36e-06	21	53	3	21337463
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	URB1 CAD SYNE2 INTS1 HELZ2 CUL9 HEATR1 UTRN	6.23e-06	653	53	8	22586326
Pubmed	Developmental loss of laminin from the interstitial extracellular matrix correlates with decreased laminin gene expression.	LAMB1 LAMC1	6.83e-06	3	53	2	2100263
Pubmed	Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network.	IFNG LDLR	6.83e-06	3	53	2	29874587
Pubmed	KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.	IFNG KSR1	6.83e-06	3	53	2	20875416
Pubmed	Differential distribution of laminin chains in the development and sex differentiation of mouse internal genitalia.	LAMB1 LAMC1	6.83e-06	3	53	2	7669546
Pubmed	A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides.	LPL LDLR	6.83e-06	3	53	2	31996466
Pubmed	Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.	LPL LDLR	6.83e-06	3	53	2	16166565
Pubmed	STAT 1 binds to the LPL promoter in vitro.	IFNG LPL	6.83e-06	3	53	2	12859963
Pubmed	Differential expression of laminin A and B chains during development of embryonic mouse organs.	LAMB1 LAMC1	6.83e-06	3	53	2	2088723
Pubmed	Laminin expression in the mouse lung increases with development and stimulates spontaneous organotypic rearrangement of mixed lung cells.	LAMB1 LAMC1	6.83e-06	3	53	2	1292752
Pubmed	Monocytic cells synthesize, adhere to, and migrate on laminin-8 (alpha 4 beta 1 gamma 1).	LAMB1 LAMC1	6.83e-06	3	53	2	11067943
Pubmed	Downregulation of a newly identified laminin, laminin-3B11, in vascular basement membranes of invasive human breast cancers.	LAMB1 LAMC1	6.83e-06	3	53	2	21276136
Pubmed	Determinants of laminin polymerization revealed by the structure of the α5 chain amino-terminal region.	LAMB1 LAMC1	6.83e-06	3	53	2	21311558
Pubmed	Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.	LPL LDLR	6.83e-06	3	53	2	9651338
Pubmed	Cell-specific effects of Dyt1 knock-out on sensory processing, network-level connectivity, and motor deficits.	TOR1A GRIN1	6.83e-06	3	53	2	34119482
Pubmed	Three-dimensional analysis of the developing pituitary gland in the mouse.	LAMB1 LAMC1	6.83e-06	3	53	2	9603432
Pubmed	Importance of nidogen binding to laminin gamma1 for branching epithelial morphogenesis of the submandibular gland.	LAMB1 LAMC1	6.83e-06	3	53	2	9043083
Pubmed	MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.	MID2 MID1	6.83e-06	3	53	2	11806752
Pubmed	Identification of laminin domains involved in branching morphogenesis: effects of anti-laminin monoclonal antibodies on mouse embryonic lung development.	LAMB1 LAMC1	6.83e-06	3	53	2	1907584
Pubmed	Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha-helix.	LAMB1 LAMC1	6.83e-06	3	53	2	6209134
Pubmed	An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients.	LAMB1 LAMC1	6.83e-06	3	53	2	12615822
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	FBN1 TNC LAMB1 LAMC1 PLXNA2	7.19e-06	175	53	5	28071719
Pubmed	A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.	LPL NR3C2 LDLR	7.51e-06	25	53	3	12544508
Pubmed	ERp57 is essential for efficient folding of glycoproteins sharing common structural domains.	LAMB1 LAMC1 LDLR	7.51e-06	25	53	3	17170699
Pubmed	Adamts18 modulates the development of the aortic arch and common carotid artery.	FBN1 LAMB1 LAMC1	8.47e-06	26	53	3	34189436
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	FBN1 ARV1 LPL TOR1A LRP4 LAMB1 LAMC1 LRP1B LDLR ADAM22	1.17e-05	1201	53	10	35696571
Pubmed	Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques.	LAMB1 LAMC1	1.36e-05	4	53	2	12820173
Pubmed	Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation.	LAMB1 LAMC1	1.36e-05	4	53	2	9885251
Pubmed	Association of lipoprotein receptor, receptor-associated protein, and metabolizing enzyme gene polymorphisms with gallstone disease: A case-control study.	LPL LDLR	1.36e-05	4	53	2	16837242
Pubmed	Role of laminin terminal globular domains in basement membrane assembly.	LAMB1 LAMC1	1.36e-05	4	53	2	17517882
Pubmed	Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy.	LAMB1 LAMC1	1.36e-05	4	53	2	19074617
Pubmed	Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression.	STAB2 LDLR	1.36e-05	4	53	2	36325910
Pubmed	Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146).	LAMB1 LAMC1	1.36e-05	4	53	2	24951930
Pubmed	Developmental regulation of the laminin alpha5 chain suggests a role in epithelial and endothelial cell maturation.	LAMB1 LAMC1	1.36e-05	4	53	2	9299121
Pubmed	MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.	MID2 MID1	1.36e-05	4	53	2	11685209
Pubmed	Regulation and Function of Laminin A5 during Mouse and Human Decidualization.	LAMB1 LAMC1	1.36e-05	4	53	2	35008625
Pubmed	A novel role of Sp1 and Sp3 in the interferon-gamma -mediated suppression of macrophage lipoprotein lipase gene transcription.	IFNG LPL	1.36e-05	4	53	2	11796707
Pubmed	Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.	LAMB1 LAMC1	1.36e-05	4	53	2	15967115
Pubmed	Depletion of nuclear actin is a key mediator of quiescence in epithelial cells.	LAMB1 LAMC1	1.36e-05	4	53	2	21172822
Pubmed	Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.	PLA2G5 LDLR	1.36e-05	4	53	2	16040605
Pubmed	Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.	LAMB1 LAMC1	1.36e-05	4	53	2	16146715
Pubmed	Laminin chain assembly. Specific sequences at the C terminus of the long arm are required for the formation of specific double- and triple-stranded coiled-coil structures.	LAMB1 LAMC1	1.36e-05	4	53	2	8034675
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	FBN1 TNC LAMB1 LAMC1	1.50e-05	97	53	4	27559042
Pubmed	The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.	PLA2G5 LDLR	2.27e-05	5	53	2	19164803
Pubmed	Ectodomains of the LDL receptor-related proteins LRP1b and LRP4 have anchorage independent functions in vivo.	LRP4 LRP1B	2.27e-05	5	53	2	20383322
Pubmed	Expression of laminin and nidogen genes during the postimplantation development of the mouse placenta.	LAMB1 LAMC1	2.27e-05	5	53	2	8286607
Pubmed	Mast cells promote atherosclerosis by releasing proinflammatory cytokines.	IFNG LDLR	2.27e-05	5	53	2	17546038
Pubmed	Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy.	LAMB1 LAMC1	2.27e-05	5	53	2	19416897
Pubmed	Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).	LPL LDLR	2.27e-05	5	53	2	19318355
Pubmed	Potential genetic markers of sporadic Alzheimer's dementia.	LPL LDLR	2.27e-05	5	53	2	11702052
Pubmed	Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo.	LAMB1 LAMC1	2.27e-05	5	53	2	8719886
Pubmed	Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.	LPL LDLR	2.27e-05	5	53	2	18635818
Pubmed	Molecular characterization of mouse and rat CPP32 beta gene encoding a cysteine protease resembling interleukin-1 beta converting enzyme and CED-3.	LPL NR3C2	2.27e-05	5	53	2	8761296
Pubmed	Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: expression pattern and assignment of the gene to mouse chromosome 19.	LPL LDLR	2.27e-05	5	53	2	8013374
Pubmed	Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.	PLA2G5 LDLR	2.27e-05	5	53	2	14962950
Pubmed	Posttranslational modifications and beta/gamma chain associations of human laminin alpha1 and laminin alpha5 chains: purification of laminin-3 from placenta.	LAMB1 LAMC1	2.27e-05	5	53	2	10964500
Pubmed	Laminin gamma2 expression is developmentally regulated during murine tooth morphogenesis and is intense in ameloblasts.	LAMB1 LAMC1	2.27e-05	5	53	2	9719032
Pubmed	Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality.	LAMB1 LAMC1	2.27e-05	5	53	2	7544312
Pubmed	Laminin-10 is crucial for hair morphogenesis.	LAMB1 LAMC1	2.27e-05	5	53	2	12743034
Pubmed	Elimination by necrosis, not apoptosis, of embryonic extraocular muscles in the muscular dysgenesis mutant of the mouse.	LAMB1 LAMC1	2.27e-05	5	53	2	14618389
Pubmed	The expression of the genes for entactin, laminin A, laminin B1 and laminin B2 in murine lens morphogenesis and eye development.	LAMB1 LAMC1	2.27e-05	5	53	2	1725162
Pubmed	Laminin 211 inhibits protein kinase A in Schwann cells to modulate neuregulin 1 type III-driven myelination.	LAMB1 LAMC1	2.27e-05	5	53	2	28636612
Pubmed	Genes coding for basement membrane glycoproteins laminin, nidogen, and collagen IV are differentially expressed in the nervous system and by epithelial, endothelial, and mesenchymal cells of the mouse embryo.	LAMB1 LAMC1	2.27e-05	5	53	2	8359228
Pubmed	Expression of collagen alpha 1(IV), laminin and nidogen genes in the embryonic mouse lung: implications for branching morphogenesis.	LAMB1 LAMC1	2.27e-05	5	53	2	7516699
Pubmed	A gene-targeting approach for functional characterization of KIAA genes encoding extremely large proteins.	INTS1 UNC79	2.27e-05	5	53	2	16807365
Pubmed	The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR.	LAMB1 LAMC1	2.27e-05	5	53	2	9647658
Pubmed	Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections.	LAMB1 LAMC1	2.27e-05	5	53	2	8613743
Pubmed	The ret finger protein-like 4 gene, Rfpl4, encodes a putative E3 ubiquitin-protein ligase expressed in adult germ cells.	RFPL4A RFPL4AL1	2.27e-05	5	53	2	11850190
Pubmed	Extracellular matrix protein fibulin-2 is expressed in the embryonic endocardial cushion tissue and is a prominent component of valves in adult heart.	LAMB1 LAMC1	2.27e-05	5	53	2	7851641
Pubmed	Mouse chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens.	IFNG LAMB1 LDLR	2.30e-05	36	53	3	9344654
Pubmed	Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice.	FBN1 LAMB1 LAMC1	2.50e-05	37	53	3	34323105
Pubmed	Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization.	LAMB1 LAMC1	3.40e-05	6	53	2	1678389
Pubmed	MEF2B is a potent transactivator expressed in early myogenic lineages.	LPL NR3C2	3.40e-05	6	53	2	8668199
Pubmed	Integrins as receptors for laminins.	LAMB1 LAMC1	3.40e-05	6	53	2	11054877
Pubmed	Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth.	LAMB1 LAMC1	3.40e-05	6	53	2	19118221
Pubmed	Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells.	LAMB1 LAMC1	3.40e-05	6	53	2	16236823
Pubmed	Impaired primary mouse myotube formation on crosslinked type I collagen films is enhanced by laminin and entactin.	LAMB1 LAMC1	3.40e-05	6	53	2	26555376
Pubmed	Effect of basement membrane entactin on epidermal cell attachment and growth.	LAMB1 LAMC1	3.40e-05	6	53	2	3794389
Pubmed	TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton.	SYNE2 TOR1A	3.40e-05	6	53	2	18827015
Pubmed	Laminin-nidogen complex. Extraction with chelating agents and structural characterization.	LAMB1 LAMC1	3.40e-05	6	53	2	3109910
Interaction	NTN5 interactions	FBN1 LRP4 LRP1B LDLR	4.03e-07	24	52	4	int:NTN5
Interaction	FBXO2 interactions	FBN1 SPRING1 SYNE2 TOR1A LAMB1 LAMC1 GRIN1 LRP1B PLXNA2	9.47e-07	411	52	9	int:FBXO2
Interaction	IGFL3 interactions	LRP4 LAMB1 LRP1B LDLR PLXNA2	1.41e-06	75	52	5	int:IGFL3
Interaction	TLNRD1 interactions	SPRING1 PLA2G5 LDLR	5.78e-06	14	52	3	int:TLNRD1
Interaction	OR56A4 interactions	OR56A4 LDLR	6.53e-06	2	52	2	int:OR56A4
Interaction	DEFB123 interactions	LRP4 LRP1B LDLR	8.86e-06	16	52	3	int:DEFB123
Interaction	ZFP41 interactions	FBN1 LRP4 LRP1B LDLR	1.41e-05	57	52	4	int:ZFP41
Interaction	ARRDC1 interactions	ZMYM2 CUL9 LAMC1 UTRN	2.84e-05	68	52	4	int:ARRDC1
Interaction	ZNF408 interactions	FBN1 MID2 LRP4 LRP1B LDLR	3.56e-05	145	52	5	int:ZNF408
Interaction	FEZF1 interactions	LRP4 CUL9 LRP1B	5.07e-05	28	52	3	int:FEZF1
Interaction	NID2 interactions	TNC LAMB1 LAMC1 GPR183	7.16e-05	86	52	4	int:NID2
Interaction	PTPRK interactions	OIT3 LAMB1 GRIN1 LRP1B PLXNA2	9.19e-05	177	52	5	int:PTPRK
Interaction	ST14 interactions	FBN1 TOR1A LAMB1 LDLR PLXNA2	1.91e-04	207	52	5	int:ST14
Interaction	DEFB136 interactions	LRP1B LDLR PLXNA2	1.99e-04	44	52	3	int:DEFB136
GeneFamily	Low density lipoprotein receptors	LRP4 LRP1B LDLR	2.05e-06	13	36	3	634
GeneFamily	Laminin subunits	LAMB1 LAMC1	2.51e-04	12	36	2	626
GeneFamily	Fibronectin type III domain containing	TRIM42 MID2 TNC MID1	2.79e-04	160	36	4	555
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM42 MID2 MID1	8.85e-04	95	36	3	59
GeneFamily	Ring finger proteins	RFPL4A TRIM42 MID2 MID1	2.10e-03	275	36	4	58
GeneFamily	Phospholipases	PLA2G5 PLCD1	3.16e-03	42	36	2	467
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	TRIM42 HEATR1	4.62e-03	51	36	2	870
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	STAB2 FBN1 MID2 TNC LAMB1 LAMC1 PLCD1 PLXNA2	9.15e-06	439	51	8	GSM777059_500
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	STAB2 FBN1 MID2 TNC LAMB1 LAMC1 PLCD1 PLXNA2	1.10e-05	450	51	8	GSM777063_500
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	FBN1 LPL LAMB1 LAMC1	8.67e-05	97	51	4	GSM777043_100
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	FBN1 TNC LPL SYNE2 LAMB1 LAMC1 PLXNA2	8.84e-05	445	51	7	GSM777043_500
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 LRP1B LDLR ADAM22	8.99e-08	186	53	6	d65fa6d8e8a195ea10cfde1499d096d6acf7a634
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 LRP1B LDLR ADAM22	8.99e-08	186	53	6	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	MID1 LAMB1 NR3C2 LRP1B RFPL4AL1	2.13e-06	176	53	5	36f77d878a53b30465b0dea8333a3865dba75613
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBN1 TNC LAMB1 PLA2G5 LAMC1	2.51e-06	182	53	5	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 LDLR ADAM22	2.58e-06	183	53	5	d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBN1 TNC LAMB1 PLA2G5 LAMC1	2.72e-06	185	53	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	(0)_MSCs\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FBN1 TNC LPL LAMB1 PLXNA2	2.80e-06	186	53	5	a832c1e0035bcd559722eccf262c145deb3494c7
ToppCell	(0)_MSCs-(00)_Lepr-MSC\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FBN1 TNC LPL LAMB1 PLXNA2	2.80e-06	186	53	5	f0d156167d7cc2cd8a76e5a364233e9f2170bc01
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 LRP1B ADAM22	2.95e-06	188	53	5	4154f4787483c7e076e87a187733a9f666742c3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 LRP1B ADAM22	3.02e-06	189	53	5	90aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 LRP1B ADAM22	3.10e-06	190	53	5	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	FBN1 TNC LAMB1 PLA2G5 LAMC1	3.26e-06	192	53	5	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	TNC LPL LAMB1 LAMC1 UTRN	3.70e-06	197	53	5	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBN1 TNC LRP4 LAMB1 ADAM22	3.89e-06	199	53	5	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FBN1 TNC LPL LAMB1 LAMC1	3.89e-06	199	53	5	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBN1 TNC LPL LAMB1 LAMC1	3.98e-06	200	53	5	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FBN1 TNC LRP4 LAMB1 ADAM22	3.98e-06	200	53	5	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 NR3C2 LRP1B ADAM22	3.31e-05	153	53	4	9b6675ace8a83c8d446b722301d0ec4e6840f3fc
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	RADX SYNE2 ZMYM2 CUL9	3.66e-05	157	53	4	f1c6c313836352271033d23efd31b0f0a8a09e02
ToppCell	RA-01._Fibroblast_I\|RA / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	4.87e-05	169	53	4	6373562ab3b1765060212a6a53d6543e7e942e80
ToppCell	Endothelial-Endothelial-G\|Endothelial / shred on cell class and cell subclass (v4)	STAB2 LAMB1 CUL9 NR3C2	5.22e-05	172	53	4	644f8e42ee8d8996f6ae50cdf874559be55509fc
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Penk_(Dentate_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OIT3 TRIM42 TEX35	5.56e-05	62	53	3	385e7de8b6d81052ee7dfc0958c7b3d924f73130
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRAPPC3L MUC19 GPR183 LRP1B	5.58e-05	175	53	4	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBN1 TNC LRP4 LAMB1	6.36e-05	181	53	4	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBN1 TNC LAMB1 LAMC1	6.36e-05	181	53	4	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBN1 TNC LAMB1 LAMC1	6.50e-05	182	53	4	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 FBN1 MID2 UTRN	6.50e-05	182	53	4	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 FBN1 MID2 UTRN	6.50e-05	182	53	4	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 FBN1 MID2 UTRN	6.50e-05	182	53	4	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 NR3C2 LRP1B ADAM22	6.78e-05	184	53	4	9690d4290e70f9bda889754ffb30b0af1f7cb94b
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	IFNG URB1 HEATR1 LDLR	6.92e-05	185	53	4	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 ADAM22	7.07e-05	186	53	4	b3358e0fa6d845c81e94d56c8575f016621d28ff
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	TNC LAMB1 PLA2G5 LAMC1	7.22e-05	187	53	4	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 ADAM22	7.22e-05	187	53	4	f6217d0dd425eac76900b44a4e48f45475f3ac36
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBN1 LAMB1 PLA2G5 LAMC1	7.37e-05	188	53	4	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	COVID-19-kidney-CD-PC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MID1 LAMB1 NR3C2 LRP1B	7.37e-05	188	53	4	8f9996c3f3b27efaaae8960a66af77412de9c7ef
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 TNC LAMB1 LAMC1	7.52e-05	189	53	4	32e6d6285b258831b965281224ff2aaeecdcb5f5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 ADAM22	7.52e-05	189	53	4	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LRP4 LAMB1 LAMC1	7.52e-05	189	53	4	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LRP4 LAMB1 LAMC1	7.52e-05	189	53	4	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	7.52e-05	189	53	4	bc54ffd7bd1627a36747a80ce5139e4a69928400
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 LRP4 LAMB1 LAMC1	7.52e-05	189	53	4	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 TNC LAMB1 LAMC1	7.52e-05	189	53	4	385ef7bbd76c8047aeecf6542377d4213b5da5db
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	URB1 FBN1 TNC LAMC1	7.68e-05	190	53	4	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	7.68e-05	190	53	4	bd0d68dc1b6f388190a6ba8a83b011619abe2bdd
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	7.68e-05	190	53	4	e275de94468872e70cf305b3b450823d4c9c5e3f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	URB1 FBN1 TNC LAMC1	7.68e-05	190	53	4	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	7.68e-05	190	53	4	ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LRP4 LAMB1 LAMC1	7.68e-05	190	53	4	9cd147a174017ebda23cc47b6d4552d898acd092
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	7.68e-05	190	53	4	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	7.68e-05	190	53	4	f3ca94a31a35eed5fecf3c4b8c957e1bc4150158
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	SYNE2 PLA2G5 UTRN PLXNA2	7.68e-05	190	53	4	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	7.68e-05	190	53	4	c2cd1eb674162ee40502c3380b7245c85079c7ce
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 LRP4 LAMB1 LAMC1	7.83e-05	191	53	4	44a9a6768084dafc641ad455b65862bfd4cc0cb9
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LRP4 LAMB1 LAMC1	7.83e-05	191	53	4	a261f0738d974784bbdd60f23092bfbcca464459
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 LRP4 LAMB1 LAMC1	7.83e-05	191	53	4	094c9d3270fc1e487ccf10fb4936af5f081f6009
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LRP4 LAMB1 LAMC1	7.83e-05	191	53	4	6594398cc8151c73696391a43ac110c10283dab1
ToppCell	facs-Lung-24m-Mesenchymal\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 LRP4 LAMB1 LAMC1	7.83e-05	191	53	4	ba02cbdfda6a94374a6472eb88499059979af472
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	7.83e-05	191	53	4	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	7.83e-05	191	53	4	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MID1 LAMB1 NR3C2 ADAM22	7.83e-05	191	53	4	96b78b4e819ea6052334bfcbc7abbf35897df885
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 LRP4 LAMB1 LAMC1	7.83e-05	191	53	4	997abf0cc5873bed0372c4a333ed307fa72774d2
ToppCell	COVID-19-kidney-CNT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MID1 NR3C2 LRP1B ADAM22	7.99e-05	192	53	4	760c6b9628de9693034b00c5025c5c4df94bb2e8
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	MID1 LAMB1 NR3C2 LRP1B	7.99e-05	192	53	4	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	7.99e-05	192	53	4	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBN1 TNC MID1 LAMB1	7.99e-05	192	53	4	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	facs-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 LRP4 LAMB1 LAMC1	7.99e-05	192	53	4	8df15085b35b86f39debd933284cb703c5dd63c2
ToppCell	droplet-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 LRP4 LAMB1 LAMC1	7.99e-05	192	53	4	086b47f87283cd41139cd56686011f8b5821b0da
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TNC LAMB1 LAMC1 PLXNA2	7.99e-05	192	53	4	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 TNC LAMB1 LAMC1	8.15e-05	193	53	4	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	8.15e-05	193	53	4	733f557bdc80293b40ccdf560f1675793df932d6
ToppCell	facs-MAT-Fat-24m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	8.15e-05	193	53	4	eb3c46b6fb06dc8708dc3032189b47ed93ee2357
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBN1 TNC LAMB1 LAMC1	8.15e-05	193	53	4	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBN1 TNC LAMB1 LAMC1	8.15e-05	193	53	4	5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	8.15e-05	193	53	4	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TNC LPL LAMB1 PLXNA2	8.15e-05	193	53	4	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	FBN1 TNC LAMB1 LAMC1	8.15e-05	193	53	4	acad568621ed677031797b8c2e34dafea798d681
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	8.15e-05	193	53	4	160691b671710be10220803d788c2c961c236af1
ToppCell	facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	8.15e-05	193	53	4	b45cd02081f97904eaea2d013e1fa980505d060b
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	8.32e-05	194	53	4	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FBN1 TNC LPL LAMB1	8.32e-05	194	53	4	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FBN1 TNC LRP4 LAMB1	8.32e-05	194	53	4	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	8.32e-05	194	53	4	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	8.32e-05	194	53	4	f906b090f67df4cfe3498cdbb52cc0efa08e06cc
ToppCell	facs-MAT-Fat-18m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	8.32e-05	194	53	4	944cdb0403d80a10a2eea2a3516a9343dbccc32c
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	FBN1 TNC LAMB1 LAMC1	8.32e-05	194	53	4	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	PND07-28-samps-Mesenchymal\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FBN1 TNC LAMB1 LAMC1	8.32e-05	194	53	4	68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d
ToppCell	facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LAMB1 LAMC1	8.32e-05	194	53	4	85081d255fcc1e9854c0073321dd9f0feaa48866
ToppCell	ASK452-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SETDB2 STAB2 ZNF571 UTRN	8.49e-05	195	53	4	20f492299a684ac1b7dd1bbc36a533cd6f9a1c93
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FBN1 TNC LAMB1 LAMC1	8.49e-05	195	53	4	78cfde21dde4b877fc76c8b0d5ddaabe44b912d7
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FBN1 MUC19 LRP4 LRP1B	8.49e-05	195	53	4	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	FBN1 LAMB1 PLA2G5 LAMC1	8.49e-05	195	53	4	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FBN1 MUC19 LRP4 LRP1B	8.49e-05	195	53	4	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FBN1 LAMB1 PLA2G5 LAMC1	8.49e-05	195	53	4	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LRP4 LAMB1	8.65e-05	196	53	4	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 LPL LRP4 LAMB1	8.65e-05	196	53	4	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	FBN1 TNC LAMB1 LAMC1	8.65e-05	196	53	4	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FBN1 MID1 PLA2G5 LAMC1	8.65e-05	196	53	4	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	T_cells-CTLs\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	IFNG SYNE2 SPG11 LDLR	8.83e-05	197	53	4	28117cf300e169182571fbad0de1681a484a435a
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRP4 LAMB1 LAMC1 LRRTM1	8.83e-05	197	53	4	1da8ba5bbab232add6e43ad78b15c2339d0c2bc3
Computational	Neighborhood of CDH11	FBN1 LAMB1 LAMC1	4.79e-05	25	31	3	GNF2_CDH11
Computational	Neighborhood of PTX3	FBN1 LAMB1 LAMC1	1.45e-04	36	31	3	GNF2_PTX3
Computational	Genes in the cancer module 401.	LPL PLA2G5	9.42e-04	16	31	2	MODULE_401
Computational	Intermediate filaments and MT.	TNC MID1 LAMB1	9.59e-04	68	31	3	MODULE_438
Computational	Genes in the cancer module 346.	PLA2G5 PLCD1	1.07e-03	17	31	2	MODULE_346
Computational	Genes in the cancer module 408.	PLA2G5 PLCD1	1.20e-03	18	31	2	MODULE_408
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	KSR1 LPL STEEP1 CUL9 UTRN ADAM22	5.52e-06	196	52	6	6785_UP
Drug	Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A	STAB2 ZMYM2 LRP4 PLCD1 LDLR ADAM22	6.02e-06	199	52	6	2822_UP
Drug	Tropine [120-29-6]; Up 200; 28.4uM; PC3; HT_HG-U133A	KSR1 URB1 PLA2G5 PLCD1 GPR183 ADAM22	6.02e-06	199	52	6	5790_UP
Drug	pifarnine	FBN1 LAMC1 LDLR	8.95e-06	18	52	3	CID006436032
Drug	Sikvav	TNC LAMB1 LAMC1	2.20e-05	24	52	3	CID005487517
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	LPL SYNE2 LRP4 SPG11 LDLR	9.72e-07	103	51	5	EFO_0008595, EFO_0020944
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	LPL SYNE2 LRP4 SPG11 LDLR	2.16e-06	121	51	5	EFO_0008595, EFO_0020943
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	LPL SYNE2 LRP4 SPG11 LDLR	2.74e-06	127	51	5	EFO_0008595, EFO_0020947
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	LPL SYNE2 HELZ2 LRP4 SPG11 LDLR	6.23e-06	264	51	6	EFO_0008317, EFO_0020944
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	LPL SYNE2 HELZ2 SPG11 LDLR	4.08e-05	222	51	5	EFO_0008317, EFO_0020943
Disease	Opitz GBBB syndrome (implicated_via_orthology)	MID2 MID1	4.37e-05	6	51	2	DOID:0080697 (implicated_via_orthology)
Disease	triglycerides in large LDL measurement	LPL SYNE2 LDLR	5.72e-05	43	51	3	EFO_0022319
Disease	Hyperlipoproteinemia	LPL LDLR	8.15e-05	8	51	2	cv:C0020476
Disease	Marfan Syndrome, Type I	FBN1 LAMC1	1.05e-04	9	51	2	C4721845
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	LPL SYNE2 SPG11 LDLR	1.14e-04	144	51	4	EFO_0004611, EFO_0020943
Disease	triglycerides in LDL measurement	LPL SYNE2 LDLR	1.26e-04	56	51	3	EFO_0022320
Disease	Pleural Diseases	IFNG TNC	1.31e-04	10	51	2	C0032226
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	LPL SYNE2 SPG11 LDLR	1.33e-04	150	51	4	EFO_0004611, EFO_0020947
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	LPL SYNE2 HELZ2 SPG11 LDLR	1.46e-04	291	51	5	EFO_0008317, EFO_0020946
Disease	Marfan Syndrome	FBN1 LAMC1	1.59e-04	11	51	2	C0024796
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	LPL SPG11 LDLR	1.63e-04	61	51	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	Endometrioma	FBN1 TNC LAMB1 NR3C2	1.75e-04	161	51	4	C0269102
Disease	Endometriosis	FBN1 TNC LAMB1 NR3C2	1.75e-04	161	51	4	C0014175
Disease	familial hyperlipidemia (implicated_via_orthology)	LPL LDLR	1.91e-04	12	51	2	DOID:1168 (implicated_via_orthology)
Disease	Hyperlipoproteinemia Type IIb	LPL LDLR	2.26e-04	13	51	2	C1704417
Disease	Hepatitis C	IFNG LPL	3.03e-04	15	51	2	C0019196
Disease	Hyperlipoproteinemia Type IIa	LPL LDLR	3.46e-04	16	51	2	C0745103
Disease	Lipidemias	LPL LDLR	3.92e-04	17	51	2	C1706412
Disease	Hyperlipidemia	LPL LDLR	3.92e-04	17	51	2	C0020473
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	LPL SYNE2 SPG11 LDLR	3.99e-04	200	51	4	EFO_0004611, EFO_0020945
Disease	Hypercholesterolemia, Familial	LPL LDLR	4.40e-04	18	51	2	C0020445
Disease	Hypertriglyceridemia	LPL LAMC1	4.92e-04	19	51	2	EFO_0004211
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	LPL HELZ2 SPG11 LDLR	6.21e-04	225	51	4	EFO_0008317, EFO_0020947
Disease	Dyslipidemias	LPL LDLR	7.89e-04	24	51	2	C0242339
Disease	Dyslipoproteinemias	LPL LDLR	7.89e-04	24	51	2	C0598784
Disease	Sjogren's syndrome (is_marker_for)	IFNG MUC19	7.89e-04	24	51	2	DOID:12894 (is_marker_for)
Disease	systemic scleroderma (is_implicated_in)	IFNG FBN1	7.89e-04	24	51	2	DOID:418 (is_implicated_in)
Disease	triglyceride measurement, intermediate density lipoprotein measurement	LPL SYNE2 LDLR	9.46e-04	111	51	3	EFO_0004530, EFO_0008595
Disease	factor VIII measurement, von Willebrand factor measurement	STAB2 AK8	1.00e-03	27	51	2	EFO_0004629, EFO_0004630
Disease	hepatitis C (is_implicated_in)	IFNG LDLR	1.08e-03	28	51	2	DOID:1883 (is_implicated_in)
Disease	von Willebrand factor measurement, coronary artery disease	STAB2 LPL AK8	1.13e-03	118	51	3	EFO_0001645, EFO_0004629
Disease	Ischemic stroke, von Willebrand factor measurement	STAB2 AK8	1.24e-03	30	51	2	EFO_0004629, HP_0002140
Disease	Adult T-Cell Lymphoma/Leukemia	IFNG GPR183	1.32e-03	31	51	2	C0023493
Disease	Mental Retardation, X-Linked 1	MID2 STEEP1	1.41e-03	32	51	2	C2931498
Disease	factor VIII measurement, venous thromboembolism	STAB2 LRP4	1.59e-03	34	51	2	EFO_0004286, EFO_0004630

Protein segments in the cluster

Peptide	Gene	Start	Entry
YQRILQCFLDRKDCC	ATG4A	111	Q8WYN0
IQCNKRDVLCGYLLC	ADAM22	591	Q9P0K1
YCAGNIIKNCICSNL	OR56A4	171	Q8NGH8
CLYNEKRIGQGILCI	RADX	136	Q6NSI4
RCYRCLLETKELGCL	LY6G5C	61	Q5SRR4
VCARDNGGCKQLCLY	LRP1B	2146	Q9NZR2
NYLCAGRNDCIIDKI	NR3C2	636	P08235
LACPLLRQLCQYQRC	INTS1	1431	Q8N201
QLCRCEGRLLYCEAL	LRRTM1	41	Q86UE6
ALLAQKYRLVNVCCG	AK8	286	Q96MA6
LYKCAAQRESCGLCL	PLXNA2	801	O75051
ECGRLQYALTCLRKV	KSR1	156	Q8IVT5
LCLSCRKNRCNNLGY	LPL	301	P06858
ICVNLKNSYRCECGV	OIT3	196	Q8WWZ8
CLCTILGNYVKACAE	MUC19	1046	Q7Z5P9
LQQDCRKCVCNYLGT	LAMB1	1021	P07942
AVQLKCGYACCLQCL	RFPL4A	21	A6NLU0
CGYACCLQCLNSLQK	RFPL4A	26	A6NLU0
LCENGRYCCLNIKEL	DEFB127	46	Q9H1M4
TEAYIRALCKGCRCL	PLCD1	326	P51178
NLCACDRKLVYCLKR	PLA2G5	106	P39877
GKLCIFCLLCEAYLR	ARV1	101	Q9H2C2
NGICENLRGTYKCIC	FBN1	736	P35555
CLGLAEEIQKYCCSR	BLVRA	281	P53004
NCNRLTGECLKCIYN	LAMC1	841	P11047
CQGLEQARKVLAYAC	CUL9	2336	Q8IWT3
QLCIVLGSLGCYCQD	IFNG	11	P01579
EKCCLLLQFILNCLY	HEATR1	1986	Q9H583
INFSCCYLCIRLEGL	HELZ2	2001	Q9BYK8
LENYQLLCNRIRGKC	UTRN	1211	P46939
AVQLKCGYACCLQCL	RFPL4AL1	21	F8VTS6
CGYACCLQCLNSLQK	RFPL4AL1	26	F8VTS6
YVCERKDLLVNGCCN	SPRING1	91	Q9H741
YCLCGQMVLVLDCQL	STEEP1	31	Q9H5V9
IAYKRCITCRLNLCN	TRIM42	246	Q8IWZ5
CLEQCGRVLELLKQY	SYNE2	1526	Q8WXH0
NLILKIFCLCCRDCQ	TEX48	6	A0A1B0GUV7
IILICYSQICCKLFR	GPR183	211	P32249
VLRQGIRDKQCYELC	URB1	1791	O60287
CRQVLCLYDLAKELG	SPG11	1991	Q96JI7
GIYECSLLCKCNRQL	SETDB2	341	Q96T68
RLYCLFAECCGQKRS	TOR1A	41	O14656
YCVTDDQLICALCKL	MID1	186	O15344
KPLCLNNCYNRGRCV	TNC	281	P24821
CSLVIQIPRCCKGYF	STAB2	1941	Q8WWQ8
LDCGLKYNQIRCLCQ	CAD	181	P27708
GLRCVTCNYCSQLCK	ZMYM2	721	Q9UBW7
LCYCNLLCGIIRGAL	TRAPPC3L	126	Q5T215
YCVSDDQLICALCKL	MID2	206	Q9UJV3
CEKCLLCALKNNYNR	TEX35	181	Q5T0J7
CKECRQGFSYLSCLI	ZNF571	141	Q7Z3V5
LNCLKILCLHGECLY	UNC79	976	Q9P2D8
QLCVNLEGGYKCQCE	LDLR	366	P01130
CNLEEFQCAYGRCIL	LRP4	191	O75096
VPQCCYGFCIDLLIK	GRIN1	451	Q05586